Generics Makers Press Australia To Lower Allowed Retail Drug Prices
This article was originally published in PharmAsia News
Australia's Generic Medicines Industry Association is pressing the Pharmaceutical Benefits Scheme to lower the prices retailers are allowed to charge for generics
You may also be interested in...
FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.